Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Pre-Exposure Prophylaxis”

395 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 395 results

Not applicableUnknownNCT06286527
What this trial is testing

Quality of Sexual Life of PrEP Users

Who this might be right for
HIV Pre-exposure Prophylaxis UseAdult
University Hospital, Grenoble 1,000
Not applicableActive Not RecruitingNCT06835751
What this trial is testing

Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania

Who this might be right for
HIVMental HealthSubstance Use (Drugs, Alcohol)
Johns Hopkins Bloomberg School of Public Health 200
Early research (Phase 1)Study completedNCT03270969
What this trial is testing

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

Who this might be right for
HIV Prevention
University of Nebraska 15
Not applicableStudy completedNCT03805451
What this trial is testing

Life Steps for PrEP for Youth

Who this might be right for
HIVPre-exposure ProphylaxisMedication Adherence
Fenway Community Health 32
Not applicableUnknownNCT03436407
What this trial is testing

Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Norway

Who this might be right for
HivSexually Transmitted DiseasesMental Health Wellness 1
Oslo University Hospital 500
Very early researchStudy completedNCT04898699
What this trial is testing

IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya

Who this might be right for
HIV
Columbia University 120
Not applicableStudy completedNCT03086200
What this trial is testing

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

Who this might be right for
Patient AdherenceHIV Seronegativity
University of California, San Diego 263
Large-scale testing (Phase 3)Study completedNCT05140954
What this trial is testing

The Women TAF-FTC Benchmark Study

Who this might be right for
HIV Infections
University of Washington 54
Post-approval studies (Phase 4)Study completedNCT03980223
What this trial is testing

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

Who this might be right for
GonorrheaChlamydiaSyphilis
University of California, San Francisco 641
Large-scale testing (Phase 3)Study completedNCT04597424
What this trial is testing

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Unsafe SexRisk-Taking
ANRS, Emerging Infectious Diseases 556
Not applicableStudy completedNCT03098693
What this trial is testing

Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania

Who this might be right for
HIV
Medical University of South Carolina 128
Large-scale testing (Phase 3)UnknownNCT06138600
What this trial is testing

Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa

Who this might be right for
HIV Infections
University of Witwatersrand, South Africa 200
Large-scale testing (Phase 3)Study completedNCT02720094
What this trial is testing

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,570
Not applicableStudy completedNCT04865341
What this trial is testing

Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men

Who this might be right for
Human Immunodeficiency Virus
Medical College of Wisconsin 118
Not applicableWithdrawnNCT02572505
What this trial is testing

Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples

Who this might be right for
HIVInfertility
University of Missouri-Columbia
Not applicableLooking for participantsNCT07683117
What this trial is testing

PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

Who this might be right for
HIV PreventionHIV Pre-exposure ProphylaxisAccess and Linkage to Healthcare+1 more
EMPOWERX INC 195
Large-scale testing (Phase 3)Active Not RecruitingNCT04994509
What this trial is testing

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 5,368
Not applicableStudy completedNCT05139069
What this trial is testing

Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women

Who this might be right for
HIV InfectionsDomestic Violence
Johns Hopkins Bloomberg School of Public Health 27
Not applicableStudy completedNCT06501885
What this trial is testing

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pre-Test Phase

Who this might be right for
HIV
Duke University 63
Not applicableStudy completedNCT06274060
What this trial is testing

Project Phakama: Testing Support Strategies to Empower Young Women on PrEP in South Africa

Who this might be right for
Pre-exposure ProphylaxisHIV Infections
Johns Hopkins Bloomberg School of Public Health 304
Next Page